ARHMS investigators have varied expertise in clinical care, epidemiology, genetics, imaging, immunology, and outcome measures and share a clear and unified vision to tackle MS in this community.
please visit us at www.arhms.org at sign for our newsletter.

The Consortium will act to implement and strategically develop tools to examine MS outcomes and eventually evaluate treatment responses specific to this population.

The intention in a broad sense is to improve our understanding of this population epidemiologically and investigate its genetic contributions to disease and MS related progression.

ARHMS is intended to build collaborative partnerships with a broad group of clinicians and researchers that both care and treat Hispanic patients with MS and have a strong interest in research within this patient population.